 Treatment dermatomyositis intravenous gammaglobulin PURPOSE mainstay pharmacologic therapy patients dermatomyositis corticosteroids patients refractory drugs drugs potential short- long-term toxicities alternate therapy desirable pilot study high-dose intravenous gammaglobulin IVGG treatment dermatomyositis PATIENTS METHODS IVGG patients juvenile dermatomyositis Prior IVGG treatment patients persistent muscle weakness daily corticosteroids patients unacceptable steroid toxicity patients toxicity immunosuppressive therapy RESULTS IVGG therapy improved muscle strength skin rash patients percentage increase muscle strength sphygmomanometry course IVGG proximal extremities proximal upper extremities IVGG therapy prednisone dose patients CONCLUSION study IVGG steroid dermatomyositis safe alternative therapy